Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins
- 1 November 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (11) , 2544-2546
- https://doi.org/10.1128/aac.41.11.2544
Abstract
MICs of DU-6859a, a novel fluoroquinolone, for 18 Klebsiella pneumoniae isolates and 21 Enterobacter cloacae isolates with altered GyrA or altered GyrA and ParC ranged from < or =0.025 to 6.25 microg/ml and from 0.1 to 3.13 microg/ml, respectively. Based on the MICs at which 90% of the isolates were inhibited for these strains of K. pneumoniae and E. cloacae, DU-6859a exhibited 16- to 256-fold-greater activity than currently available fluoroquinolones.Keywords
This publication has 11 references indexed in Scilit:
- Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IVJournal of Antimicrobial Chemotherapy, 1997
- Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve methodJournal of Antimicrobial Chemotherapy, 1996
- Topoisomerase IV is a target of quinolones in Escherichia coli.Proceedings of the National Academy of Sciences, 1995
- Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteersAntimicrobial Agents and Chemotherapy, 1995
- Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone‐resistant isolatesMolecular Microbiology, 1994
- Mechanism of action of quinolones against Escherichia coli DNA gyraseAntimicrobial Agents and Chemotherapy, 1993
- Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coliAntimicrobial Agents and Chemotherapy, 1993
- Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolatesAntimicrobial Agents and Chemotherapy, 1992
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990